Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience

BACKGROUND/AIM: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: KILIÇ, Levent, KARADAĞ, Ömer, ERDEN, Abdulsamet, SARI, Alper, ARMAĞAN, Berkan, YARDIMCI, Gözde Kübra, FIRAT, Esra, KALYONCU, Umut, APRAŞ BİLGEN, Şule, KİRAZ, Sedat, ERTENLİ, İhsan, AKDOĞAN, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080363/
https://www.ncbi.nlm.nih.gov/pubmed/31655524
http://dx.doi.org/10.3906/sag-1906-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080363/
https://www.ncbi.nlm.nih.gov/pubmed/31655524
http://dx.doi.org/10.3906/sag-1906-39

Ejemplares similares